Trials / Withdrawn
WithdrawnNCT03766750
Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.
Randomized, Double-blind, Multicenter, National, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Lima association in the control of type 2 diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LIMA association | 1 coated tablet, oral, once a day. |
| DRUG | Tradjenta | 1 coated tablet, oral, once a day. |
| DRUG | Forxiga | 1 coated tablet, oral, once a day. |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2023-10-01
- Completion
- 2023-11-01
- First posted
- 2018-12-06
- Last updated
- 2022-07-27
Source: ClinicalTrials.gov record NCT03766750. Inclusion in this directory is not an endorsement.